tiprankstipranks
Clinuvel Pharmaceuticals Limited (DE:UR9)
STUTTGART:UR9

Clinuvel Pharmaceuticals Limited (UR9) Ownership - Who Owns Clinuvel Pharmaceuticals Limited?

1 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 20, 2023
Philippe Jacques Wolgen
Chief Executive Officer & Managing Director
BoughtAU$29814
Jun 28, 2023
Philippe Jacques Wolgen
Chief Executive Officer & Managing Director
BoughtAU$27147

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,500Insider50,490
3,148Insider28,899
3,425,222Insider31,443,538
196,577Insider1,804,577
420Insider3,856
187,774Insider1,723,765
1,743,118Insider16,001,823
1,000Insider9,180
162,195Insider1,488,950
108,224Insider993,496

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
5,000Institution48,780
656Institution6,400
12,708Institution123,979
816Institution7,961
6,455Institution62,975
2,335Institution22,780
300,118Institution2,927,951
8,967Institution87,482
18,967Institution185,042
10,768Institution105,053

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Clinuvel Pharmaceuticals Limited (DE:UR9)?
Currently, no data Available
What percentage of Clinuvel Pharmaceuticals Limited (DE:UR9) stock is held by institutional investors?
Currently, no data Available
What percentage of Clinuvel Pharmaceuticals Limited (DE:UR9) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Clinuvel Pharmaceuticals Limited (DE:UR9)?
Karen Agersborg owns the most shares of Clinuvel Pharmaceuticals Limited (DE:UR9).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis